A Phase III, Double-Blind, Placebo-Controlled, Randomized Study Of Ipatasertib In Combination With Atezolizumab And Paclitaxel As A Treatment For Patients With Locally Advanced Unresectable Or Metastatic Triple-Negative Breast Cancer

  • Kefford, Richard (Primary Chief Investigator)
  • Chapman, Nicola, (Clinical Trial Unit Staff)
  • Parshionikar, Abhijit, (Clinical Trial Unit Staff)
  • Rajasekharan Nair, Archana, (Clinical Trial Unit Staff)

Project: Other

Project Details

AcronymIPATunity170
StatusActive
Effective start/end date22/11/1930/09/24